Vetmab Biosciences, Inc.
Monoclonal antibodies for veterinary therapeutic applications
- Sector
- Biotech
- Headquarters
- SAN FRANCISCO, CA
- Founded
- 2022
- Latest Form D
- $11.4M, Sep 2026
- Total capital
- $14M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $14M
- 4 Form D · last Sep 2026
- 1 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 10 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 4th filing$11.4M
- Private capital raisedForm D · SEC · 3rd filing$575K
- Private capital raisedForm D · SEC · 2nd filing$2M
- Private capital raisedForm D · SEC · 1st filing$22
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Denise Marie BeversExecutive Officer, DirectorNamed in SEC Form D filings
- Hangjun Marie ZhanDirectorNamed in SEC Form D filings
- Richard Marie ChinDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 10- PendingANTI-IL23 AND ANTI-TNFa ANTIBODIES: COMPOSITIONS AND VETERINARY USEUSPTOApplication 19138328
- PendingFcrn Antagonists For Veterinary UseUSPTOApplication PCTUS2024061845
- PendingFcRn ANTAGONISTS FOR VETERINARY USEUSPTOApplication 63711570
Show all 10 patent records
- ANTI-IL23 AND ANTI-TNFa ANTIBODIES: COMPOSITIONS AND VETERINARY USEJul 23, 2026 · Application 19138328Pending
- Fcrn Antagonists For Veterinary UseApplication PCTUS2024061845Pending
- FcRn ANTAGONISTS FOR VETERINARY USEApplication 63711570Pending
- Long-acting Glucagon-like Peptide 1 Receptor (GLP1R) Agonists For Veterinary UseApplication PCTUS2024049607Pending
- FcRn ANTAGONISTS FOR VETERINARY USEApplication 63615130Pending
- ANTI-IL23 And Anti-tnfa Antibodies: Compositions And Veterinary UseApplication PCTUS2023084003Pending
- Long-acting Glucagon-like Peptide 1 Receptor (GLP1R) Agonists For Veterinary UseApplication 63587503Pending
- ANTI-IL23 AND ANTI-TNFa ANTIBODIES: COMPOSITIONS AND VETERINARY USEApplication 63387777Pending
- Long-acting Glucagon-like Peptide 1 Receptor (GLP1R) Agonists For Veterinary UseApplication 19524792Pending
- FcRn ANTAGONISTS FOR VETERINARY USEApplication 19601248Pending
Related companies, and why
- CARAVEL BIO, INC.Similar federal contract value in Biotech · null in contracts
- Resilient Biotics, Inc.Similar federal contract value in Biotech · null in contracts
- Model Medicines, Inc.Similar federal contract value in Biotech · null in contracts
- Mercury Bio, Inc.Similar federal contract value in Biotech · null in contracts
- Accipiter Biosciences Inc.Similar federal contract value in Biotech · null in contracts
- LAVO LIFE SCIENCES INCSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .